• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评价慢性病的多维结局:来自中国的临床实例。

Evaluation of multi-dimensional outcomes of chronic diseases: a clinical example from China.

机构信息

Department of Social Medicine, Public Health School, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, PR China.

出版信息

Arch Gerontol Geriatr. 2011 May-Jun;52(3):e106-9. doi: 10.1016/j.archger.2010.08.005. Epub 2010 Oct 30.

DOI:10.1016/j.archger.2010.08.005
PMID:21036408
Abstract

The purpose of this study is to provide the evidence of individualized/personalized care by evaluating multi-dimensional outcomes of chronic diseases in the elderly. We used primary osteoporosis as an example, to evaluate the outcomes of three treatments (calcium combined vitamin D=Ca+vit.D; estrogen and disphosphonates) at the same time with biological dimension (bone-mineral density=BMD) and socio-psychological dimension (health-related quality of life=HR-QOL), using the medical outcomes study short-form 36-item health survey (SF-36) and cost dimension (drug cost). Using BMD as the outcome index, disphosphonate was the most effective treatment, in terms of HR-QOL, estrogen was the most effective while Ca+vit.D was the cheapest treatment, namely, different dimensional outcomes with different results. Outcome evaluation of chronic diseases in the elderly needs to combine psychological and socio-economic parameters together with the physiological measurement, to encourage a transition from "the disease-centered" to "the patient-centered" perspective as well as achieve sustainable and coordinated development of health and socio-economic resources.

摘要

本研究旨在通过评估老年人慢性病的多维结局提供个体化/个性化护理的证据。我们以原发性骨质疏松症为例,同时使用生物维度(骨矿物质密度=BMD)和社会心理维度(健康相关生活质量=HR-QOL),以及成本维度(药物成本),用医疗结局研究简表 36 项健康调查(SF-36)评估三种治疗方法(钙加维生素 D=Ca+vit.D;雌激素和双磷酸盐)的结局。以 BMD 为结局指标,双磷酸盐治疗最有效,在 HR-QOL 方面,雌激素最有效,而 Ca+vit.D 则是最便宜的治疗方法,即不同维度的结局有不同的结果。老年人慢性病的结局评估需要将心理和社会经济参数与生理测量相结合,鼓励从“以疾病为中心”向“以患者为中心”的转变,并实现卫生和社会经济资源的可持续和协调发展。

相似文献

1
Evaluation of multi-dimensional outcomes of chronic diseases: a clinical example from China.评价慢性病的多维结局:来自中国的临床实例。
Arch Gerontol Geriatr. 2011 May-Jun;52(3):e106-9. doi: 10.1016/j.archger.2010.08.005. Epub 2010 Oct 30.
2
[Quality of life in the treatment assessment of postmenopausal osteoporosis].[绝经后骨质疏松症治疗评估中的生活质量]
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2005 Jun;30(3):299-303.
3
Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.阿仑膦酸钠联合补充钙和维生素D对治疗HIV患者骨矿物质密度降低是安全有效的。
AIDS. 2007 Nov 30;21(18):2473-82. doi: 10.1097/QAD.0b013e3282ef961d.
4
[The role of vitamin D in the treatment of osteoporosis in the elderly].[维生素D在老年骨质疏松症治疗中的作用]
Med Klin (Munich). 2006 Jun;101 Suppl 1:15-9. doi: 10.1007/s00063-006-9003-9.
5
Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium.糖皮质激素性骨质疏松症的预防与治疗:骨化三醇、维生素D加钙以及阿仑膦酸钠加钙的比较
J Bone Miner Res. 2003 May;18(5):919-24. doi: 10.1359/jbmr.2003.18.5.919.
6
A cost effectiveness analysis of calcium and vitamin D supplementation, etidronate, and alendronate in the prevention of vertebral fractures in women treated with glucocorticoids.钙和维生素D补充剂、依替膦酸二钠和阿仑膦酸钠预防接受糖皮质激素治疗女性椎体骨折的成本效益分析。
J Rheumatol. 2003 Jan;30(1):132-8.
7
Antiresorption therapy and reduction in fracture susceptibility in the osteoporotic elderly patient: open study.抗吸收疗法与老年骨质疏松症患者骨折易感性降低:开放性研究
Eur Rev Med Pharmacol Sci. 2004 Mar-Apr;8(2):97-102.
8
Importance of calcium, vitamin D and vitamin K for osteoporosis prevention and treatment.钙、维生素D和维生素K在骨质疏松症预防和治疗中的重要性。
Proc Nutr Soc. 2008 May;67(2):163-76. doi: 10.1017/S0029665108007003.
9
Health-economic comparison of three recommended drugs for the treatment of osteoporosis.三种推荐用于治疗骨质疏松症的药物的卫生经济学比较
Int J Clin Pharmacol Res. 2004;24(1):1-10.
10
Randomized controlled trial of the effects of calcium with or without vitamin D on bone structure and bone-related chemistry in elderly women with vitamin D insufficiency.钙联合或不联合维生素D对维生素D缺乏老年女性骨结构及骨相关化学指标影响的随机对照试验
J Bone Miner Res. 2008 Aug;23(8):1343-8. doi: 10.1359/jbmr.080327.

引用本文的文献

1
Osteoporosis in East Asia: Current issues in assessment and management.东亚地区的骨质疏松症:评估与管理中的当前问题
Osteoporos Sarcopenia. 2016 Sep;2(3):118-133. doi: 10.1016/j.afos.2016.07.001. Epub 2016 Jul 30.
2
Management of osteoporosis with calcitriol in elderly Chinese patients: a systematic review.老年华裔患者应用骨化三醇治疗骨质疏松症的管理:系统评价。
Clin Interv Aging. 2014 Mar 28;9:515-26. doi: 10.2147/CIA.S40465. eCollection 2014.
3
Molecular Mechanisms of Same TCM Syndrome for Different Diseases and Different TCM Syndrome for Same Disease in Chronic Hepatitis B and Liver Cirrhosis.
慢性乙型肝炎和肝硬化同病异证和异病同证的分子机制。
Evid Based Complement Alternat Med. 2012;2012:120350. doi: 10.1155/2012/120350. Epub 2012 May 30.